ENTRY       D11533                      Drug
NAME        Zagotenemab (USAN)
FORMULA     C6448H9976N1712O2026S44
EXACT_MASS  145215.7934
MOL_WEIGHT  145305.3178
SEQUENCE    (Heqvy chain)
            EVQLVQSGAE VKKPGESLKI SCKGSGYTFS NYWIEWVRQM PGKGLEWMGE ILPGSDSIKY
            EKNFKGQVTI SADKSISTAY LQWSSLKASD TAMYYCARRG NYVDDWGQGT LVTVSSASTK
            GPSVFPLAPC SRSTSESTAA LGCLVKDYFP EPVTVSWNSG ALTSGVHTFP AVLQSSGLYS
            LSSVVTVPSS SLGTKTYTCN VDHKPSNTKV DKRVESKYGP PCPPCPAPEA AGGPSVFLFP
            PKPKDTLMIS RTPEVTCVVV DVSQEDPEVQ FNWYVDGVEV HNAKTKPREE QFNSTYRVVS
            VLTVLHQDWL NGKEYKCKVS NKGLPSSIEK TISKAKGQPR EPQVYTLPPS QEEMTKNQVS
            LTCLVKGFYP SDIAVEWESN GQPENNYKTT PPVLDSDGSF FLYSRLTVDK SRWQEGNVFS
            CSVMHEALHN HYTQKSLSLS LG
            (Light chain)
            EIVLTQSPGT LSLSPGERAT LSCRSSQSLV HSNQNTYLHW YQQKPGQAPR LLIYKVDNRF
            SGIPDRFSGS GSGTDFTLTI SRLEPEDFAV YYCSQSTLVP LTFGGGTKVE IKRTVAAPSV
            FIFPPSDEQL KSGTASVVCL LNNFYPREAK VQWKVDNALQ SGNSQESVTE QDSKDSTYSL
            SSTLTLSKAD YEKHKVYACE VTHQGLSSPV TKSFNRGEC
            (Disulfide bridge: H22-H96, H130-L219, H143-H199, H222-H'222, H225-H'225, H257-H317, H363-H421, H'22-H'96, H'130-L'219, H'143-H'199, H'257-H'317, H'363-H'421, L23-L93, L139-L199, L'23-L'93, L'139-L'199)
  TYPE      Peptide
EFFICACY    Anti-tau protein antibody
  TYPE      Monoclonal antibody
COMMENT     Treatment of Alzheimer's disease and other tauopathies
TARGET      MAPT (TAU) [HSA:4137] [KO:K04380]
  PATHWAY   hsa04010(4137)  MAPK signaling pathway
            hsa05010(4137)  Alzheimer disease
            hsa05022(4137)  Pathways of neurodegeneration - multiple diseases
BRITE       Target-based classification of drugs [BR:br08310]
             Not elsewhere classified
              Cellular process
               Cytoskeleton
                MAPT (TAU)
                 D11533  Zagotenemab (USAN)
DBLINKS     CAS: 2019133-28-7
            PubChem: 384585509
///
